B-CELL LEUKEMIA
Clinical trials for B-CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B-CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for B-CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Dual-Targeting CAR T-Cell therapy offers hope for relapsed childhood leukemia
Disease control Recruiting nowThis study tests a new treatment for children and young adults (ages 3-39) with B-cell cancers like leukemia or lymphoma that have come back after standard therapy. The treatment uses a patient's own immune cells, which are modified in a lab to target two cancer proteins (CD19 an…
Matched conditions: B-CELL LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
New CAR-T therapy targets tough blood cancers in early trial
Disease control Recruiting nowThis early-phase trial tests a new treatment called CLIC-2201 for people with certain blood cancers (like lymphoma or leukemia) that have not responded to standard therapy or have returned. The treatment uses a patient's own immune cells, which are modified in a lab to better rec…
Matched conditions: B-CELL LEUKEMIA
Phase: PHASE1 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New CAR-T therapy targets leukemia that escaped previous treatments
Disease control Recruiting nowThis study tests a new type of immunotherapy for patients with a form of B-cell leukemia that does not have the CD19 marker, or has returned after CD19-targeted treatment. The therapy uses the patient's own immune cells, modified to recognize several other markers on the cancer c…
Matched conditions: B-CELL LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
Leukemia treatment may erase vaccine immunity – study seeks answers
Knowledge-focused Recruiting nowThis study looks at whether children and young adults (up to age 21) treated for B-cell acute lymphoblastic leukemia with the drug blinatumomab still have protection from routine childhood vaccines. Researchers will measure antibody levels for diseases like tetanus, hepatitis B, …
Matched conditions: B-CELL LEUKEMIA
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated May 26, 2026 12:02 UTC